The DABOM

The Decisive and Advanced
Bio-Operator for Medicine

The Decisive and
Advanced Bio-Operator
for Medicine

The DABOM Inc. is a specialized platform company that
mass-produces artificial exosomes using microfluidics
technology and artificial intelligence(AI).

More View
diagnostics

Technology

diagnostics

Artificial Exosomes
for Nanomedicine (ExocureTM)

Detail View
diagnostic kit

Artificial Exosome Mass-Producing Platform
(ExostationTM)

Detail View
diagnostic kit

Products/Service

Detail View

Pipeline - R&D Schedule

Exosome-based therapeutics

Detail View

The DABOM Notice

The DABOM Inc. and EDmicBio Inc. Sign MOU for Joint Development of Exosome-Loaded Bio-Ink

2025-05-29

The DABOM Inc. and EDmicBio Inc. Sign MOU for Joint Development of Exosome-Loaded Bio-Ink
Dr. Hyo-Il Jung, CEO of The DABOM Inc., Appointed President of the Korea BioChip Society 2025

2025-05-28

Dr. Hyo-Il Jung, CEO of The DABOM Inc., Appointed President of the Korea BioChip Society 2025
The DABOM Inc. Signs RCA with Baiya Phytopharm and PlantForm

2025-04-12

The DABOM Inc. Signs RCA with Baiya Phytopharm and PlantForm
CES 2025: Successfully Showcasing The DABOM Inc.'s Innovations and Vision to the World

2025-01-21

CES 2025: Successfully Showcasing The DABOM Inc.'s Innovations and Vision to the World
Dr. Hyo-Il Jung, CEO of The DABOM Inc., Attends the 2025 UKF 82 Startup Summit

2025-01-21

Dr. Hyo-Il Jung, CEO of The DABOM Inc., Attends the 2025 UKF 82 Startup Summit
The DABOM Inc. Selected for DeepTech TIPS

2025-01-21

The DABOM Inc. Selected for DeepTech TIPS
The DABOM Inc. at CES 2025

2025-01-10

The DABOM Inc. at CES 2025
Get a Sneak Peek of the CES 2025 Seoul Pavilion IR Pitching! play icon

2025-01-04

Get a Sneak Peek of the CES 2025 Seoul Pavilion IR Pitching!
CEO Hyo-Il Jung Attends SUP Family Day

2024-12-18

CEO Hyo-Il Jung Attends SUP Family Day
The DABOM Inc. to Showcase at [CES 2025 Seoul Pavilion]

2024-12-18

The DABOM Inc. to Showcase at [CES 2025 Seoul Pavilion]
CFO Jong-Ho Park Receives Commendation from the Minister of SMEs and Startups

2024-12-11

CFO Jong-Ho Park Receives Commendation from the Minister of SMEs and Startups
CEO Hyo-Il Jung Delivers Invited Lecture at the 2024 Korean Society for Extracellular Vesicles Annua

2024-09-04

CEO Hyo-Il Jung Delivers Invited Lecture at the 2024 Korean Society for Extracellular Vesicles Annua
CEO Hyo-Il Jung Delivers Keynote Address at the International Conference on Nanotechn

2024-07-17

CEO Hyo-Il Jung Delivers Keynote Address at the International Conference on Nanotechn
The DABOM Inc. Signs MOU with PlantForm Corp. for Therapeutic Artificial Exosome Technology Developm

2024-03-15

The DABOM Inc. Signs MOU with PlantForm Corp. for Therapeutic Artificial Exosome Technology Developm
The DABOM Inc. Attends the 2024 EVIA Annual General Meeting

2024-02-01

The DABOM Inc. Attends the 2024 EVIA Annual General Meeting
The DABOM Inc. Presents Two Research Findings Orally at the 2023 Korean Society for Extracellular Ve

2023-11-14

The DABOM Inc. Presents Two Research Findings Orally at the 2023 Korean Society for Extracellular Ve
CEO Hyo-Il Jung Receives the KSEV Achievement Award

2023-11-14

CEO Hyo-Il Jung Receives the KSEV Achievement Award
The DABOM Inc. Signs MOU with One BioMed Pte. Ltd. for the Development of Ultra-Rapid Exosome Analys

2023-10-31

The DABOM Inc. Signs MOU with One BioMed Pte. Ltd. for the Development of Ultra-Rapid Exosome Analys
The DABOM Inc. Signs MOU with KIST Europe for European Market Entry

2023-10-26

The DABOM Inc. Signs MOU with KIST Europe for European Market Entry
The DABOM Inc. Awarded Top Honors in Yonsei University’s Lab Startup Program

2023-07-12

The DABOM Inc. Awarded Top Honors in Yonsei University’s Lab Startup Program
close